What is Rapport Therapeutics, Inc.'s operating cash flow?

Rapport Therapeutics, Inc. (RAPP) reported operating cash flow of -$13.06M in Q1 2026.

How has Rapport Therapeutics, Inc.'s operating cash flow changed year-over-year?

Rapport Therapeutics, Inc.'s operating cash flow increased by 35.5% year-over-year, from -$20.24M to -$13.06M.

What does operating cash flow mean?

Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Rapport Therapeutics, Inc. RAPP Operating Cash Flow

Operating Cash Flow at other companies

Bristol-Myers SquibbBMY

$1.1B-43.5%

Supernus PharmaceuticalsSUPN

$66.52M+117%

Xenon PharmaceuticalsXENE

-$88.9M-44.2%

Praxis Precision Medicines, Inc.PRAX

-$86.15M-62.5%

BiohavenBHVN

-$149.92M+9.2%

Septerna, Inc.SEPN

-$25.63M-9.8%

Other financials

Income statement

See full

Revenue$20.0M—

Operating income-$24.2M+10.7%

Net income-$19.9M+17.5%

EPS (diluted)-$0.42+38.2%

Balance sheet

See full

Cash & equivalents$78.1M+35.5%

Total debt$10.8M+37.8%

Total equity$471.5M+65.0%

Total assets$497.6M+64.7%

Cash flow

See full

CapEx$86.0K-70.4%

Free cash flow-$13.1M+36.0%

Valuation

See full

Market cap$1.86B+309%

Enterprise value$1.79B+352%

Returns & leverage

See full

Return on equity-28.3%—

Debt / equity0×0.0×

Current ratio27.1×-3.9×

Where this comes from

Reported directly by Rapport Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapport Therapeutics, Inc.'s operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rapport Therapeutics, Inc.'s operating cash flow?: Rapport Therapeutics, Inc. (RAPP) reported operating cash flow of -$13.06M in Q1 2026.
How has Rapport Therapeutics, Inc.'s operating cash flow changed year-over-year?: Rapport Therapeutics, Inc.'s operating cash flow increased by 35.5% year-over-year, from -$20.24M to -$13.06M.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.